Role of endogenous endothelin on coronary flow in health and disease

Coronary Artery Disease

Volumn 12, Issue 6, 2001, Pages 517-525

  Goodwin, Andrew T ^a   Yacoub, Magdi H ^b  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Bosentan; Coronary tone; Endothelin; Heart; Heart failure; Hypertension; Ischaemia; Reperfusion

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; PLACEBO;

AGING; ARTERY TONE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HUMAN; HYPERTENSION; INTRACORONARY INFUSION; ISCHEMIA; LIVER TOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASODILATATION;

ANIMALS; CARDIOVASCULAR DISEASES; CORONARY CIRCULATION; ENDOTHELINS; HUMANS; RATS;

EID: 0034773677     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200109000-00012     Document Type: Review

References (111)

1. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart
2. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart
3. Role of endothelium-formed nitric oxide on vascular responses
4. Endothelium-mediated regulation of coronary tone
5. Maintenance of 'basal' vascular tone may represent a physiological role for endothelin
6. Endothelial control of vascular tone in large and small coronary arteries
7. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
8. The discovery of endothelins
9. Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells
10. Cloning and expression of a cDNA encoding an endothelin receptor
11. Effects of endothelin-1 in isolated perfused rat heart
12. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo
13. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells
14. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle
15. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction
16. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium
17. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells
18. Control of endothelial cell gene expression by flow
19. Polar secretion of endothelin-1 by cultured endothelial cells
20. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells
21. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension
22. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
23. Endothelin in human congestive heart failure
24. Elevated endothelin-1 in heart failure and loss of normal response to postural change
25. Increased plasma endothelin concentrations in patients with acute heart failure after myocardial infarction
26. Endothelins
27. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor
28. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat
29. Endothelin-1-induced myocardial ischaemia and oedema in the rat: Involvement of the ETA receptor, platelet-activating factor and thromboxane A2
30. Proarrhythmic activity of intracoronary endothelin in dogs: Relation to the site of administration and to change in regional flow
31. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide
32. Effects of endothelin-1 on the rat isolated heart
33. Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig
34. Vasodilator action of endothelin-1 in the perfused rat heart
35. Role of endogenous endothelin in the regulation of basal coronary tone in the rat
36. Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs
37. Effect of endothelin on the function of the isolated perfused working rat heart
38. Effects of endothelin-1 in the isolated heart under ischemic and cardioplegic conditions
39. Effects of endothelin on the coronary vascular bed in open-chest dogs
40. Lethal ischemia due to intracoronary endothelin in pigs
41. Effects of endothelin on regional blood flows in squirrel monkeys
42. Effect of endothelin on total and regional coronary resistance and on myocardial contractility
43. Influence of endothelin on human coronary arteries and localization of its binding sites
44. 125l]endothelin-1 in humans, pigs, and rats: Functional relevance in humans
45. Effect of endothelin on normal and diseases human coronary arteries
46. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery
47. Cardiopulmonary effects of endothelin-1 in man
48. Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans
49. Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans
50. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease
51. Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography
52. Serotonin response increases with age in rat coronary resistance arteries
53. Physiology of cardiovascular ageing
54. Ageing is associated with reduced basal and stimulated release of nitric oxide by the coronary endothelium
55. Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion
56. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury
57. Release of endothelin during reperfusion of ischemic myocardium. ET-1 release from reperfused heart
58. Release of endothelin from the porcine heart after short term coronary artery occlusion
59. Endothelin in myocardial infarction
60. Circulating endothelin in patients undergoing coronary artery bypass grafting
61. Inhibition of endogenous endothelin during eardioplegia improves low coronary reflow following prolonged hypothermic arrest
62. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats
63. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion
64. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart - Attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610
65. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial isehaemic and reperfusion injury in the pig
66. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat
67. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats
68. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044
69. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts
70. Endothelin-receptor antagonist FR 139317 reduces infarct size in a rabbit model when given before, but not after, coronary artery occlusion
71. Effects of endothelin-1, and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts
72. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation
73. Role of endothelin in a rabbit model of acute myocardial infarction: Effects of receptor antagonists
74. Inhibition of inositol(1,4,5)triphosphate generation by endothelin-1 during postischemic reperfusion. A novel antiarrhythmic mechanism
75. Role of endothelin in the exercise intolerance of chronic heart failure
76. Inhibition of myocardial endothelin pathway improves long term survival in heart failure
77. Endothelin-01 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active mixed endothelin ETA and ETB receptor antagonist
78. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function
79. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure
80. Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors
81. Evidence for endothelin-l-mediated vasoconstriction in severe chronic heart failure
82. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
83. Multicenter, double-blind, placebo-controlled study of long-term endothelin blockade with bosentan in chronic heart failure. Results of the REACH-1 trial
84. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
85. Update of REACH-1 and MERIT-HF clinical trials in heart failure
86. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats
87. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model
88. Role of endogenous endothelin-1 in experimental renal hypertension in dogs
89. Hypertension associated with endothelin-secreting malignant hemangioendothelioma
90. Preliminary evidence for homeostatic mechanism regulating endothelin production in pre-eclampsia
91. Plasma endothelin is increased in young essential hypertensives but not in elderly essential or diabetic hypertensives
92. Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males
93. The effect of regulation of high blood pressure on plasma endothelin-1 levels in blacks with hypertension
94. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury
95. Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury
96. Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat
97. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis
98. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 309670
99. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs
100. Increases of vascular endothelin-converting enzyme activity and endotherin-1 lever on atherosclerotic lesions in hyperlipidemic rabbits
101. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol
102. Elevated endothelin levels in patients with hyperlipoproteinemia
103. Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis
104. Endothelin in coronary endothelial dysfunction and early atheroscrerosis in humans
105. Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: Pathophysiological implications in coronary disease
106. Endothelin-1 and endothelin-receptor mRNA expression in normal and atherosclerotic human arteries
107. Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions
108. 125l-labeled endothelin-1 binding in rat cardiac membranes
109. Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty
110. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart
111. Endothelin-1 and myocardial preconditioning